Search results
Estée Lauder Cuts Revenue Outlook on China Weakness
Bloomberg via Yahoo Finance· 57 minutes ago(Bloomberg) -- Estée Lauder Cos. lowered its revenue outlook for the remainder of the year as the company faces lackluster demand for its high-end...
How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.
Motley Fool via Yahoo Finance· 1 hour agoDeidre Woollard: Good segue. The other craze, of course, weight-loss drugs. We've got some news on...
Baird starts Praxis shares coverage with outperform, cites promising drug By Investing.com
Investing.com· 3 hours agodrug candidate, ulixacaltamide, will be a significant treatment option for essential tremors,...
Biden gives cannabis industry a badly needed win
Axios· 3 hours agoThe U.S. Drug Enforcement Agency is recommending that cannabis be reclassified as a Schedule III drug, which would codify that it has medicinal value and...
Saudi Chemical Giant’s Profit Slumps as Pressures Persist
Bloomberg via Yahoo Finance· 35 minutes ago(Bloomberg) -- Saudi Arabia’s top chemicals company reported a 62% drop in year-on-year profit as...
What Marijuana Reclassification Means for the United States
Time Magazine· 1 hour agoThe Justice Department proposal would recognize the medical uses of cannabis, but wouldn't legalize...
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Zacks via Yahoo Finance· 2 hours agoThe key question now is: What could be the stock's future direction? Although media reports or...
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
Business Insider via Yahoo Finance· 14 hours agoThe world's biggest healthcare company said it experienced surging demand for its GLP-1 Zepbound...
No. 1 Biotech Stock Pops After Biggest Moneymaker Tops Sales Views
Investor's Business Daily· 1 hour agoThe company makes Ingrezza, a treatment for the movement disorder known as tardive dyskinesia.
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks via Yahoo Finance· 1 hour agoThe company registered adjusted earnings of 16 cents per share in the first quarter of 2023....